LINC 2018 live case guide


Find all live cases and live case centers listed below.

 

 

Cookie notice
In order to use the Issuu PDF reader, you will have to consent to the use of cookies categorized under "External Services".
Open cookie settings

New York

2 livecase(s)
  • Tuesday, January 30th: - , Room 1 - Main Arena 1

    Case 05 – Right superficial femoral diffuse severe disease

    Center:
    New York
    Case 05 – NY 01: female, 66 years (E-M)
    Operators:
    • Prakash Krishnan,
    • Karthik Gujja,
    • S. Singla,
    • Rheoneil Lascano
    CLINICAL DATA
    - Patient presents with 2 block life-style limiting lower extremity claudication
    - over last 6 months. Progressively worsening. Rutherford Category 3.
    - No history of ulcer. Failed maximal medical therapy.
    - ABI: right 0.71, left 0.92

    RISK FACTORS
    - Hypertension, ex smoker, dyslipidemia
    - CAD s/p CABG
    - PVD - s/p left fempop bypass

    PROCEDURAL STEPS
    1. Left groin access with retrograde cross over approach
    - UF 4F diagnostic catheter (ANGIO DYNAMICS)
    - 0.035" SupraCore guidewire, 300 cm (ABBOTT VASCULAR)
    - 7F–45 cm Pinnacle sheath (TERUMO)
    2. Passage through the right SFA stenosis
    - 0.035" Tempo Aqua Vert support catheter, 125 cm (CORDIS)
    - 0.014" Fielder guidewire, 300 cm (ABBOTT VASCULAR)
    - Exchange to 0.014" Spartacore guidewire, 300 cm (ABBOTT VASCULAR)
    3. Filter placement
    - Exchange to a Barewire through the support catheter (ABBOTT VASCULAR)
    - Emboshield Nav 6 filter placement (ABBOTT VASCULAR)
    4. Plaque modification
    - Chocolate balloon 5 x 120 mm (MEDTRONIC)
    5. PTA with drug-coated balloon
    - In.Pact Admiral 6.0 x 150 mm DCB (MEDTRONIC)
    View image
  • Tuesday, January 30th: - , Room 1 - Main Arena 1

    Case 08 – Right superficial femoral artery occlusion – calcified

    Center:
    New York
    Case 08 – NYo2: male, 80 years, (H-P)
    Operators:
    • Prakash Krishnan,
    • Vishal Kapur,
    • Karthik Gujja,
    • S. Singla,
    • Rheoneil Lascano
    CLINICAL DATA
    - Progressively worsening right leg claudication x 1 year
    - No history of rest pain or ulceration
    - Has failed maximal medical therapy
    - Current claudication distance <1 block (Rutherford stage 3)
    - ABI: right 0.82, left 0.94

    RISK FACTORS
    - Type 2 diabetes mellitus, hypertension, dyslipidemia, ex smoker
    - History of CAD s/p CABG

    PROCEDURAL STEPS
    1. Left groin access with retrograde cross over approach
    - UF 4F diagnostic catheter (ANGIO DYNAMICS)
    - 0.035" SupraCore guidewire, 300 cm (ABBOTT VASCULAR)
    - 6F–45 cm Pinnacle sheath (TERUMO)
    2. Passage through the right SFA occlusion
    - 0.035" Tempo Aqua Vert support catheter, 125 cm (CORDIS)
    - 0.018" Connect 250 T guidewire, 300 cm (ABBOTT VASCULAR)
    - If unable to cross with 0.018" guidewire, switch to an 0.035" stiff angled glidewire (TERUMO)
    3. Filter placement
    - Exchange to a Barewire through the support catheter (ABBOTT VASCULAR)
    - Emboshield Nav 6 filter placement (ABBOTT VASCULAR)
    4. Jetstream atherectomy of the right SFA calcified disease
    - Jetstream 2.4/3.4 mm atherectomy (BOSTON SCIENTIFIC)
    5. PTA with drug-coated balloon
    - In.Pact Admiral 6.0 x 120 mm DCB (MEDTRONIC)
    6. PTA with a non-compliant balloon
    - Dorado 6 x 100 mm balloon (BARD)
    7. Stenting and post-dilatation
    - 5.5 x 150 mm Supera interwoven self-expanding Nitinol stent (ABBOTT)
    - Dorado 6 x 100 mm balloon (BARD)
    View image
Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.

For more infos on the cookies we use and how you can manage them, please visit our cookie policy.

  • We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • Our website makes use of external services such as Issuu and Push-Panda. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.